Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study

By sjmartinez • October 4, 2024

Syal G, Mishkin DS, Banty A, Lee S, Fontelera N, Hampton M, Ziring D, Fleshner PR, Melmed GY. Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study. Inflamm Bowel Dis. 2024 Oct 3;30(10):1907-1910. doi: 10.1093/ibd/izad191. PMID: 37898112.

Tags: calprotectin, Cedars Sinai DoM, chronic pouchitis, Digestive Diseases, modified pouch disease activity index, Publications, tofacitinib

Accelerated 3D qCEST of the Spine in a Porcine Model Using MR Multitasking at 3T

Cheema K, De Righi DR, Shen C, Lee HL, Kaneda G, Wechsler J, Chavez M, Avalos P, Floyd C, Tawackoli W, Xie Y, Christodoulou AG,[...]

The evolving risk of infective endocarditis after transcatheter aortic valve implantation

Alabbadi SH, Iribarne A, Rodés-Cabau J, Doenst T, Chikwe J, Itagaki S, Toyoda N, Makkar R, Akowuah EF, Perez M, Bandettini WP, Akhter SA, Bleiziffer[...]

The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States

Singh V, Cheng S, Velazquez A, Trivedi HD, Kwan AC. The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults[...]